General Western Blot Reagents
Abcam 1400W, iNOS inhibitor, 50MG
MW 250.17 Da, Purity >97%. Selective iNOS inhibitor, 5000-fold selective over eNOS (Kd values are ≤7 nM, 2 μM and 50 μM at human iNOS, nNOS and eNOS, respectively).
The product is subject to the following: Abcam Restricted Use Statement
Abcam Defero x amine mesylate, Iron chelator, 1G
MW 656.8 Da. Iron chelator. Blood-brain barrier permeable. Displays a number of biological actions such as immunomodulation, inhibition of inflammation and atherosclerosis, and reduction of neuronal death.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Phorbol 12-myristate 13-acetate (PMA), PKC activator, 25MG
Phorbol 12-myristate 13-acetate (PMA), PKC activator is a potent nanomolar activator of protein kinase C in vivo and in vitro. Binds to C1 domain of protein kinase C, induces membrane translocation and enzyme activation. Also reported to have actions on non-kinase proteins including chimaerins, RasGRP and Unc-13/Munc-13. Extremely potent mouse skin tumor promoter. - Cited in over 45 publications - Purity > 99% - Supplied in DMSO (10mM)
The product is subject to the following: Abcam Restricted Use Statement
Abcam NF-kappaB Activation Inhibitor VI, benzo x athiole compound, 25MG
MW 273.4 Da, Purity >95%. Cell-permeable benzoxathiole compound that acts as an IKK-2 inhibitor, presumably by targeting the Ser¹⁷⁷ and/or Ser¹⁸¹ residues in the kinase's activation loop domain. Shown to inhibit LPS-induced NF-κB activation (IC₅₀ = 1.0 μM) and nitrite production (IC₅₀ = 0.7 μM) in RAW 264.7 cells in vitro and effectively prevent LPS-induced septic death in mice in vivo.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Thiazolyl blue tetrazolium bromide (MTT), membrane-permeable dye, 5G
MW 414.3 Da, Purity >98%. Thiazolyl blue tetrazolium bromide (MTT), membrane-permeable dye. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Mitomycin C (MMC), Anticancer and antibiotic agent, 10MG
MW 334.33 Da, Purity >99%. Anticancer and antibiotic agent. Crosslinks DNA. Inhibits DNA synthesis and nuclear division. Also induces apoptosis.
The product is subject to the following: Abcam Restricted Use Statement
Abcam APC/Cy7 Conjugation Kit - Lightning-Link, 3 x 100UG
Labeling in < 4 hrs with 30 secs hands-on time using APC/Cy7 Conjugation Kit - Lightning-Link ab102859. 100% antibody recovery.
The product is subject to the following: Abcam Restricted Use Statement
Abcam APC/Cy5.5 Conjugation Kit - Lightning-Link, 100UG
Labeling in < 4 hrs with 30 secs hands-on time using APC/Cy5.5 Conjugation Kit - Lightning-Link ab102855. 100% antibody recovery.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Western Blot Stripping Buffer, 500ML
Western Blot Stripping Buffer (ab282569) uniformly removes antibodies from Western blots so that the blots may be reprobed with different antibodies.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Dynorphin A, kappa agonist, 1MG
MW 2147.51 g/mol. Endogenous potent κ agonist. Analgesic effects in vivo and involved in cardiovascular regulation.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Alkaline Phosphatase Enhancer, 250ML
To use as signal enhancer in conjunction with alkaline phosphatase based immunostaining systems.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Bortezomib, proteasome inhibitor, 25MG
MW 384.2 Da, Purity >98%. Potent, selective, reversible proteasome inhibitor (Ki = 0.6 nM). Inhibits proliferation of a number of tumor cell lines (IC₅₀ = 7 nM). Inhibits TNF synthesis and FGF-induced angiogenesis.
The product is subject to the following: Abcam Restricted Use Statement
Abcam 7-Diethylaminocoumarin-3-carbo x ylic acid N-succinimidyl ester, Fluorescent labeling reagent, 100MG
MW 358.35 g/mol, Purity >95%. Fluorescent labeling reagent for amine-containing biomolecules. Used in labeling of amino acids prior to resolution by capillary zone electrophoresis.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Mertansine (DM1 Compound), microtubule-targeted cytoto x ic agent, 25MG
MW 738.3 Da. Potent microtubule-targeted cytotoxic agent. Induces mitotic arrest. Inhibits microtubule polymerization. Shows antitumor effects in vivo. .
The product is subject to the following: Abcam Restricted Use Statement
Boston Bioproducts Inc Stripping Buffer (4X, Medium) - 500ml
The 4X Stripping Buffer (Medium) is a less stringent stripping solution comprising of glycine and the detergents such as SDS and Tween-20. It is used for breaking antibody-antigen interactions, resulting in removal of primary and secondary antibodies from probed Western blot membranes without significantly affecting the immobilized proteins. This solution enables reprobing Westen blot membranes several times with different antibodies, preventing the need for running multiple gels and transfers.
